Here's Why Editas Medicine Dropped Today

Here's Why Editas Medicine Dropped Today

Shares of Editas Medicine (NASDAQ: EDIT) are down 10.7% at 1:50 p.m. EST today on no apparent news other than it's a high-flying biotech that's fallen out of favor with biotech investors of late. Investors are likely still a little spooked about a change in leadership at Editas after James Mullen took over the CEO role from Cynthia Collins earlier this month.